Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Clean Energy Fuels
CLNE
5
American Express
AXP
US Stock MarketDetailed Quotes
Barinthus Biotherapeutics (BRNS)
- 0.7280
- +0.0180+2.54%
Close Jan 22 15:13 ET
29.72MMarket Cap-0.39P/E (TTM)
0.7450High0.7100Low21.56KVolume0.7100Open0.7100Prev Close15.62KTurnover0.06%Turnover RatioLossP/E (Static)40.83MShares2.920052wk High0.35P/B26.23MFloat Cap0.640052wk Low--Dividend TTM36.04MShs Float17.9900Historical High--Div Yield TTM4.93%Range %0.6400Historical Low0.7240Avg Price1Lot Size
Barinthus Biotherapeutics (BRNS) Key Financial Indicators
BRNS Earnings per Share (EPS)
According to the latest financial report of Barinthus Biotherapeutics, the latest earnings per share (TTM) for the company is -0.36. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
BRNS Free Cash Flow (FCF)
Interested in knowing about Barinthus Biotherapeutics's free cash flow? The latest report shows it as -10.73M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
BRNS Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Barinthus Biotherapeutics shows that the company's current ratio is 8.04, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
BRNS Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Barinthus Biotherapeutics, the quick ratio is 7.33, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
BRNS Return on Equity (ROE)
Want to learn more about the financial health of Barinthus Biotherapeutics? The latest ROE figure is -15.59%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
BRNS Return on Assets (ROA)
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Barinthus Biotherapeutics, the total asset return on investment (ROA) is -12.20%.
Currency: USD
Quarterly
Loading...
BRNS Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Barinthus Biotherapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
BRNS Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Barinthus Biotherapeutics, the net profit margin is -54.31%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec
今日熱門
Dec 11, 2025 03:27
December FOMC Interest Rate Meeting
牛牛課堂
Dec 19, 2025 12:28
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?